Original Research ARTICLE
Multiomics Assessment of Gene Expression in a Clinical Strain of CTX-M-15-Producing ST131 Escherichia coli
- 1Department of Genetics and Biotechnology, School of Life and Environment Sciences, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal
- 2Functional Genomics and Proteomics Unit, School of Life and Environment Sciences, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal
- 3Veterinary Science Department, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal
- 4Área de Bioquímica y Biología Molecular, Universidad de La Rioja, Logroño, Spain
- 5Departamento de Microbiologia II, Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain
- 6LAQV-REQUIMTE, Faculty of Science and Technology, Nova University of Lisbon, Lisbon, Portugal
- 7Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health, Lisbon, Portugal
- 8Technology and Innovation Unit, Department of Human Genetics, National Institute of Health, Lisbon, Portugal
- 9CECAV, Centro de Ciência Animal e Veterinária, Universidade de Trás-os-Montes e Alto Douro, Vila Real, Portugal
Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli strain C999 was isolated of a Spanish patient with urinary tract infection. Previous genotyping indicated that this strain presented a multidrug-resistance phenotype and carried beta-lactamase genes encoding CTX-M-15, TEM-1, and OXA-1 enzymes. The whole-cell proteome, and the membrane, cytoplasmic, periplasmic and extracellular sub-proteomes of C999 were obtained in this work by two-dimensional gel electrophoresis (2DE) followed by fingerprint sequencing through matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS). A total of 602 proteins were identified in the different cell fractions, several of which are related to stress response systems, cellular responses, and antibiotic and drug responses, consistent with the multidrug-resistance phenotype. In parallel, whole genome sequencing (WGS) and RNA sequencing (RNA-Seq) was done to identify and quantify the genes present and expressing. The in silico prediction following WGS confirmed our strain as being serotype O25:H4 and sequence type ST131. The presence of proteins related to antibiotic resistance and virulence in an O25:H4-ST131 E. coli clone are serious indicators of the continued threat of antibiotic resistance spread amongst healthcare institutions. On a positive note, a multiomics approach can facilitate surveillance and more detailed characterization of virulent bacterial clones from hospital environments.
Rates of Gram-negative healthcare-associated infections have been increasing since 1998, mostly caused by antimicrobial resistant Enterobacteriaceae. A strikethrough recent worldwide survey revealed the prevalence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in 14% of healthy individuals, a rate predicted to increase by 5.38% year on year overall (Karanika et al., 2016; Bassetti et al., 2017). Patients hospitalized in intensive care units and in long-term care facilities, or those who are immunocompromised have a higher risk of acquiring multidrug-resistant Gram-negative infections (Kunz and Brook, 2010). ESBLs are enzymes encoded by plasmid-borne genes, typically from the TEM, SHV, CTX-M families, that mediate resistance to oxyimino-beta-lactam antibiotics, third-generation cephalosporins and aztreonam (Rice, 2009; Drawz and Bonomo, 2010). For years, Escherichia coli producing the CTX-M-15 variant have been frequently implicated in human infection (Ewers et al., 2010). It has also been noted that the blaCTX-M-15 gene is located 49 bp downstream of insertion sequence ISEcp1, a well-known highly efficient mobile element playing a major role in the expression and spread of CTX-M beta-lactamases, the most common in Europe (Peirano and Pitout, 2010; Guiral et al., 2011). Throughout the years, the ciprofloxacin-resistant CTX-M-15-producing O25:H4-ST131 E. coli clonal group is known to have caused major outbreaks worldwide (Nicolas-Chanoine et al., 2008; Ewers et al., 2010; Johnson et al., 2017). Classed as a member of the virulent phylogenetic group B2 and having the multidrug-resistant profile of the sequence type (ST) 131 clonal group, the O25:H4-ST131 clone represents a major public health problem as it makes it more complicated to select an appropriate therapy to administer, with a higher risk of increased costs and use of “last resort” antibiotics (Vimont et al., 2012). ST131 is therefore seen as being at the leading edge of a deeply concerning set of increasingly challenging infection agents (Vimont et al., 2012; Johnson et al., 2017). In the present work, we studied an ESBL-producing E. coli strain of human clinical origin, designated C999, that was previously studied and characterized by Ruiz et al. (2012). C999 was resistant to fluoroquinolones and third generation cephalosporins because of CTX-M-15 ESBL and belonged to phylogenetic group B2 and ST131. According to the genomic profile of E. coli C999 we assumed that this strain is related to the hazardous intercontinental O25:H4-ST131 clone. In our research, we took a multiomics approach to more deeply characterize this significant clinical strain. Whole-genome sequencing (WGS) and RNA sequencing (RNA-Seq) analysis were conducted to confirm if the E. coli C999 strain belongs to the O25:H4 serotype and identify/quantify the genes expressed. In parallel, proteomic maps of C999 were produced by two-dimensional gel electrophoresis (2DE) of whole-cell and fractionated extracts followed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS) of peptides (Vlaanderen et al., 2010). This allowed us to monitor how resistance mechanisms affect the proteomes of the membrane and cytoplasmic compartments.
Materials and Methods
Total DNA was extracted from E. coli C999 using a silica-based automatic DNA extractor EasyMag (BioMérieux Inc., Durham, United States). A sequencing library was generated using the Nextera XT DNA library preparation kit (Illumina Inc., San Diego, CA, United States) and sequenced on a MiSeq (Illumina Inc., San Diego, CA, United States) using paired-end reads (2 × 150 bp), according to the manufacturer’s instructions. FastQC1 and Trimmomatic2 software tools were used for read quality analysis and improvement, respectively (D’Antonio et al., 2015; Williams et al., 2016). Genome assembly and annotation were done using SPAdes3 and RAST annotation4, respectively. Finally, putative antimicrobial resistance genes were predicted using Comprehensive Antibiotic Resistance Database (CARD5) (Jia et al., 2017). WGS raw reads were submitted to the European Nucleotide Archive under the accession numbers ERR3013427.
RNA Library Preparation and Sequencing
Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Venlo, Netherlands) with RNase-free DNase treatment on the column (Qiagen), followed by bacterial rRNA depletion using a Ribo-Zero rRNA Removal Kit (Illumina Inc., San Diego, CA, United States). The 2100 Bioanalyzer (Agilent, Santa Clara, CA, United States) was used to evaluate the concentration and quality of RNA samples pre- and post-depletion. For RNA-Seq analysis, a library was prepared with rRNA-depleted samples using the TruSeq Stranded mRNA LT Sample Prep Kit (Illumina). RNA was sequenced on a MiSeq using paired-end (2 × 75 bp) reads (Illumina), according to the manufacturer’s instructions.
Transcriptomic Data Analysis
The quality of raw RNA-Seq data was evaluated using FastQC analysis. The sequence reads were then mapped against the obtained whole-genome sequence of strain C999 using the Bowtie2 algorithm6 (Version 2.1.0). The expression level of each transcript was calculated using the Cufflinks software7 (Version 2.1.1) by normalizing data as fragments per kilobase of coding sequence per million mapped reads (FPKM).
Whole-Cell Protein Extraction
Cells were grown in brain heart infusion agar for 24 h and afterward cultivated in brain heart infusion broth (15 ml) for 4 h (Goncalves et al., 2014). Exponentially growing cells were then harvested by centrifugation (3 min, 10,000 g, 4°C) and resuspended in 4 ml of phosphate-buffered saline at room temperature, centrifuged again, then resuspended in 0.2 ml of 10% (w/v) sodium dodecyl sulfate (SDS), 12% (w/v) Tris (Celis and Gromov, 1999). Cells were disrupted by sonication with an ultrasonic homogenizer (Vibra-CellTM VCX130, Sonics & Materials Inc., Newtown, United States) in three 10 s bursts at 40% of full power, then cell debris was removed by centrifugation (14,000 g, 30 min, 4°C). The clear supernatant was collected then mixed with an equal volume of cold 20% (w/v) trichloroacetic acid (TCA; Merck, Darmstadt, Germany) in acetone (Sigma-Aldrich, St. Louis, MO, United States) and was kept at -20°C for 1 h. The precipitate was collected by centrifugation at 13,000 g for 30 min at 4°C. The precipitated protein was washed thrice with acetone to remove traces of TCA. Residual acetone was removed by air-drying. Protein pellets were solubilized in thiourea/urea lysis buffer. The resulting solutions were stored at -80°C for further analysis.
Extracellular Protein Extraction
Extracellular proteins were prepared as previously described with some modifications (Nandakumar et al., 2006; Xia et al., 2008; Goncalves et al., 2014). Cells were removed from brain heart infusion broth culture by centrifugation at 5500 g for 10 min at 4°C. The clear supernatant was collected, passed through a 0.22 μm filter, mixed with an equal volume of cold 20% (w/v) TCA in acetone, and kept at -20°C for 1 h. The precipitate formed after centrifugation at 13,000 g for 30 min at 4°C was washed thrice with acetone to remove traces of TCA, and residual acetone was removed by air-drying. Dried protein pellets were solubilized in thiourea/urea lysis buffer [2 M thiourea, 7 M urea, 4% (w/v) CHAPS, 1% (w/v) dithiothreitol (DTT), 2% (v/v) carrier ampholytes (pH 3–10) and 10 mM Pefabloc® proteinase inhibitor], then stored at -80°C for further analysis.
Periplasmic and Cytoplasmic Protein Extraction
To extract periplasmic and cytoplasmic protein from bacterial cultures, the Epicentre PeriprepsTM Periplasting kit (Epicentre, WI, United States) was used with a few modifications to the kit protocol. The bacterial cell culture was centrifuged at 5500 g for 10 min and the supernatant discarded. The pellet was resuspended by pipetting in 2 ml of PeriPrepsTM Periplasting buffer (200 mM Tris-HCl pH 7.5, 20% sucrose, 1 mM EDTA, and 30 U/μl Ready-Lyse lysozyme) for each gram of cell pellet. The sample was incubated for 5 min at room temperature. Osmotic shock was induced by rapidly adding 3 ml of ice-cold water for each gram of original cell pellet, mixing the sample by inverting the centrifuge tubes. The sample was kept on ice for 10 min then centrifuged at 12,000 g for 2 min to separate the pellet (spheroplasts and intact cells) from the supernatant, the periplasmic fraction. Spheroplasts in the pellet were lysed by adding a detergent lysis buffer (10 mM KCl, 1 mM EDTA, and 0.1% deoxycholate) and the pellet was resuspended in 5 ml of PeriPreps lysis buffer for each gram of original cell pellet and incubated for 5 min at room temperature. The sample was sonicated with 2 s bursts at 40% of full power for a total of 1 min. Cell debris was removed by centrifugation at 12,000 g for 15 min at 4°C. The supernatant was removed and centrifuged as before. The supernatant recovered was the cytoplasmic fraction. Equal volumes of cold 20% (w/v) TCA in acetone were mixed with both periplasmic and cytoplasmic fractions that were then kept at -20°C Tris-HCl pH 7.5, 50 for 1 h. The precipitates collected after centrifugation at 13,000 g for 30 min at 4°C were washed thrice with acetone to remove traces of TCA. Residual acetone was removed by air-drying. Protein pellets were solubilized in thiourea/urea lysis buffer and stored at -80°C for further analysis.
Membrane Protein Extraction
Membrane proteins were isolated by a previously described method with some modifications (Taddei et al., 2011). Bacterial cells were recovered from liquid culture by centrifugation at 10,000 g for 3 min at 4°C and the pellet was resuspended in phosphate-buffered saline pH 7.4 (Gorg et al., 2004). After a second similar centrifugation step, the pellet was resuspended in 25 ml of 10 mM Tris buffer pH 8.8 with 1 mM phenylmethylsulfonylfluoride (Sigma-Aldrich). Cells were disrupted with 3 cycles of 20 s bursts of sonication at 40% of full power and the cell debris was removed by centrifugation at 12,000 g for 2 min at room temperature. The supernatant was centrifuged at 49,500 g for 60 min at 4°C (in a 3–30KS centrifuge with rotor no.12158, Sigma GmbH, Osterode am Harz, Germany) and the pellet was treated with 1.67% N-lauroylsarcosine sodium salt (Sigma-Aldrich) for 20 min at room temperature. The membrane proteins were recovered by centrifugation at 23,000 g for 90 min at 4°C and the pellet was solubilized in thiourea/urea lysis buffer. Samples were stored at -80°C for further analysis.
Protein concentration was determined using the 2-D Quant kit (GE Healthcare, Buckinghamshire, United Kingdom) following the manufacturer’s instructions. In this procedure proteins are quantitatively precipitated leaving other substances in solution. The precipitated proteins are then resuspended in a copper-containing solution with the unbound copper being measured with a colorimetric agent. Color density (absorbance at 480 nm) is thus inversely related to the protein concentration and accurately reflects the protein concentration of the sample.
One-Dimensional and Two-Dimensional Electrophoresis
One-dimensional electrophoresis was done with SDS-polyacrylamide (SDS-PAGE) gels (T = 12.52%, C = 0.97%) in a HoeferTM SE 600 Ruby® unit (GE Healthcare, Chicago, United States) as described by Laemmli (1970) with some modifications (Igrejas, 2000). Whole-cell protein extract (15 μg) was resuspended in an equal volume of buffer containing 0.5 M Tris HCl pH 8.0, glycerol, SDS and bromophenol blue. After protein separation at 30 mA, gels were stained for 24 h in Coomassie Brilliant Blue R-250 and washed in water overnight. Gels were then fixed in 6% TCA for 4 h and in 5% glycerol for 2 h (Gorg et al., 2009). Two-dimensional electrophoresis (2DE) was performed according to the principles of O’Farrell but with ImmobilineTM pH Gradient (IPG) technology (O’Farrell, 1975; Gorg et al., 2009). For the first dimension of isoelectric focusing, precast 13 cm IPG strips with linear gradients of pH 3–10 (GE Healthcare) were passively rehydrated for 12–16 h in a reswelling tray with 250 μl of rehydration buffer (8M urea, 1% CHAPS, 0.4% DTT, and 0.5% carrier ampholyte IPG buffer pH 3–10) at room temperature. IPG strips were covered with Drystrip Cover Fluid (Plus One, GE Healthcare). Lysis buffer [9.5 M urea, 1% (w/v) DTT, 2% (w/v) CHAPS, 2% (v/v) carrier ampholytes (pH 3–10), and 10 mM Pefabloc® proteinase inhibitor] was added to E. coli protein extracts to achieve a concentration of 1 μg/μl of protein. Samples containing a total of 100 μg of protein were cup-loaded onto the rehydrated 13-cm IPG strips (Gorg et al., 2009). To optimize running conditions, isoelectric focusing replicate runs were performed according to Gorg et al. (2009) and the GE Healthcare protocol for 13 cm IPG strips pH 3–10 on an EttanTMIPGPhor IITM (GE Healthcare). The optimized 13 h run was as follows: sample proteins were focused at 500 V for 1 h, followed by a gradient up to 1000 V for 8 h, then a gradient up to 8000 V for 3 h, finally remaining at 8000 V for 1 h. Focused IPG strips were then stored at -80°C in plastic bags. Before running the second dimension of electrophoresis, strips were equilibrated twice for 15 min in equilibration buffer [6M urea, 30% (w/v) glycerol, 2% (w/v) SDS in 0.05M Tris-HCl buffer (pH 8.8) with bromophenol blue] with 1% DTT included in the first equilibration and 4% iodoacetamide in the second one. The equilibrated IPG strips were briefly rinsed with SDS electrophoresis buffer, blotted to remove any excessive buffer, and then loaded onto 12.52% polyacrylamide gels in a HoeferTM SE 600 Ruby® unit (GE Healthcare). The SDS-PAGE technique previously reported by Laemmli (1970) was modified to increase the resolution with the proper insertion of the IPG strips in the stacking gel (Laemmli, 1970; Igrejas, 2000). SDS-PAGE was run at 440 V for 3 h. Gels were fixed in 40% methanol, 10% acetic acid for 1 h, then stained overnight in Coomassie Brilliant Blue G-250 (Gorg et al., 2009). Coomassie-stained gels were scanned on a flatbed scanner (UmaxPowerLook 1100, Freemont, CA, United States) and the digitized images were analyzed using Lab Scanner Image Master 5.0 software (GE Healthcare). Protein molecular weights were estimated by comparison with an internal calibration marker.
Protein Identification by MALDI-TOF/MS
For each extraction method, gels were analyzed and compared with each other. Spots that were expressed in all gels were manually excised from the gels and analyzed using MALDI-TOF/MS. Gel pieces were rehydrated twice in 200 μl Milli-Q water and washed twice with 25 mM ammonium bicarbonate, 50% acetonitrile (ACN), once with 50 μl ACN, then dried in a SpeedVac (Thermo Fisher Scientific, Waltham, MA, United States). To digest the proteins, 15 μl of trypsin solution [0.02 μg/μl trypsin (Promega, Madison, WI, United States), 12.5 mM ammonium bicarbonate, 2% (v/v) can] was added to the dried gel pieces, which were then kept on ice for 1 h before adding 30 μl of 12.5 mM ammonium bicarbonate and incubating them overnight at 37°C. Tryptic peptides were extracted by adding 20 μl of 5% formic acid, 50% ACN and then 25 μl of 50% ACN, 0.1% trifluoroacetic acid followed by threefold lyophilization in a SpeedVac (Thermo Fisher Scientific). Tryptic peptides were resuspended in 10 μl of 0.3% formic acid. Samples were mixed (1:2, v/v) with 1 μl of a saturated matrix solution of 5 mg/ml α-cyano-4-hydroxycinnamic acid in 0.1% (v/v) trifluoroacetic acid, 50% (v/v) ACN, 8 mM ammonium phosphate). Aliquots of samples (0.5 μl) were spotted onto the MALDI sample target plate (384-spot ground-steel plate). Peptide mass spectra were obtained from a MALDI-TOF/MS Ultraflex mass spectrometer (Bruker Daltonics, Bremen, Germany) operating in positive ion reflectron-mode. Spectra were acquired in the m/z range of 600–3500 Da at a laser frequency of 50 Hz. For each spot analyzed, a data-dependent acquisition method was created to select the six most intense peaks, excluding those from the matrix, trypsin autolysis, or acrylamide, for subsequent MS/MS data acquisition. Mass spectra were internally calibrated with self-digested trypsin peaks (MH+: 842.5, 2211.42 Da) allowing a mass accuracy of better than 25 ppm. External calibration was performed with the [M + H]+ monoisotopic peaks of bradykinin 1–7 (m/z 757.3992), angiotensin II (m/z 1046.5418), angiotensin I (m/z 1296.6848), substance P (m/z 1758.9326), ACTH clip 1–17(m/z 2093.0862), ACTH18–39 (m/z 2465.1983), and somatostatin 28 (m/z 3147.4710).
Bioinformatics Analysis for Proteomics
Spectra were processed and analyzed using the Global Protein Server Workstation (Applied Biosystems), which uses internal MASCOT software (v 2.1.04, Matrix Science, London, United Kingdom) to search for peptide mass fingerprints within MS/MS data. The Swiss-Prot non-redundant protein sequence database (Release 10 of October 2014, 546790 entries) and NCBI Reference Sequence Database (RefSeq release 68 of November 2014, 46968574 protein entries) were used to search E. coli protein sequences. The database search parameters were as follows: carbamidomethylation and propionamide of cysteine (+71 Da) and oxidation of methionine (+16 Da) as variable modifications, allowance for up to two missed tryptic cleavages, peptide mass tolerance of 50 ppm, and fragment ion mass tolerance of 0.3 Da. Positive identifications were accepted above 95% of confidence level. Protein identifications were considered as reliable when the MASCOT score was >70% calculated as –10 × log P, where P is the probability that the observed match is a random event. This is the lowest score indicated by the program as being significant (P < 0.05) below which proteins are likely to be incorrectly identified.
Results and Discussion
E. coli C999 Strain Profile
Genomics and Transcriptomics
ESBL-producing E. coli strain C999, implicated in a urinary infection of a Spanish patient was collected in 2007 and used in this study, thus characterized in relation to the phenotype and genotype of antimicrobial resistance and to molecular typing (Ruiz et al., 2012). This strain was resistant to ampicillin, amoxicillin/clavulanic acid, cefotaxime, ceftazidime, naladixic acid, ciprofloxacin, tobramycin, kanamycin, streptomycin, tetracycline, sulfamides and trimethoprim-sulfametoxazole, and carried the blaCTX-M-15, blaOXA-1, and blaTEM-1b β-lactamase genes. Other resistance genes observed in strain C999 were aac(6’)-Ib-cr (ciprofloxacin resistance), tet(A) (tetracycline resistance) and sul1 (sulfametoxazole resistance). The gene cassette array dfrA17 + aadA5 was observed in strain C999 and mutations were also found in genes encoding GyrA (Ser83Leu + Asp87Asn) and ParC proteins (Ser80Ile + Glu84Val) (Ruiz et al., 2002). C999 was classified in the phylogenetic group B2, mostly implicated in extraintestinal infections (Clermont et al., 2000), and it belongs to sequence type ST131, as previously detected (Ruiz et al., 2012). To better understand the nature of the C999 strain we produced a comprehensive survey of its genome, transcriptome and proteome. WGS allowed comprehensive characterization of the genetic makeup of the bacterial strain, including the identification of antibiotic resistance genes, consistent with the known pathological nature of this strain previously determined by Ruiz and colleagues (Ruiz et al., 2012). In fact, in silico prediction was applied to the WGS assay using SerotypeFinder 2.0, thus confirming the O25:H4 serotype which can lead us to acknowledge our strain as a member of the O25:H4-ST131 E. coli clonal group (Joensen et al., 2015). Supplementary Table S1 display all the identified genes related to antibiotic resistance such as aac(6’)-Ib-cr, tet(A), sul1, aadA5 gene cassette and genes related to toxin-antitoxin addiction systems of plasmids pemK, ccdA/ccdB, vagC/vagD, and sok, as well as β-lactamase genes blaTEM-1, blaOXA-1, and blaCTX-M-15. It is important to also highlight the presence of several stress response and oxidoreductase genes. This perspective of the C999 transcriptome gives an overview of all its cellular mechanisms (Supplementary Table S2).
The 2DE gels of the whole-cell proteome and four sub-proteomes of E. coli strain C999 were compared (Figures 1, 2). From all the gels, a total of 564 protein spots were collected for analysis using MALDI-TOF/MS and identified by correlating the output with bioinformatics databases8. A total of 602 different proteins were identified from 471 different spots, which corresponds to 83.51% of the total spots collected (Supplementary Tables S5–S9). The proteins identified were related to different functions within bacterial cell metabolism, the most frequent being enzyme activity, transport and molecule/protein biosynthesis, followed by the stress response, the SOS response and antibiotic resistance (Figures 3–5). Proteins related to glycolysis and molecule biosynthesis were indeed well represented in all proteomes (Figure 6). In fact, 282 different proteins were identified as involved in biological processes of regular cell functioning and 42 proteins were found to be related to stress response mechanisms, as has been previously described (Micevski and Dougan, 2013; Delmar et al., 2014).
Figure 1. Whole-cell proteome of E. coli C999. One-dimensional SDS-PAGE gel profile stained with Coomassie R-250 (left) with schematic profile showing molecular weights. Two-dimensional gel stained with Coomassie G-250 with spots marked (right). Protein spot color key: dark red, stress response; orange, SOS response; dark green, antibiotic resistance.
Figure 2. Two-dimensional gel of E. coli C999 of extracellular (A), periplasmic (B), membrane (C), and cytoplasmic (D) proteome fractions stained with Coomassie G-250 with spots marked (right). Protein spot color key: dark red, stress response; orange, SOS response; dark green, antibiotic resistance.
Figure 3. Distribution of E. coli strain C999 proteins according to their predicted function in biological processes.
Figure 4. Distribution of E. coli strain C999 proteins from cytoplasm and membrane fractions according to their predicted function in biological processes.
Figure 5. Distribution of E. coli strain C999 proteins from extracellular and periplasm fractions according to their predicted function in biological processes.
Figure 6. Comparison of protein distribution among the different cellular fractions and whole-cell extract.
Comparison of RNA and Proteins Expressed in E. coli C999
With the use of RNA-Seq the abundance of all transcripts was quantified, thus allowing to compare the gene expression levels to the proteomic data (Supplementary Table S3; Han et al., 2015; Salipante et al., 2015). Supplementary Table S4 summarizes the relevant genes identified with their lengths and abundance in FPKMs, juxtaposed with the proteomic data obtained and corresponding protein score. Taking an overview of all the data obtained, it is interesting to see that among the top-100 most highly expressed genes only 25 corresponded to detected proteins, whereas only 80 detected proteins were among the top-500 expressed genes. In fact, gene blaCTX-M-15 was identified with an expression level of 355 FPKM being placed in the top-1000 although not being detected at the proteome level. The lack of correlation between mRNA and protein expression was already referred in previous studies, where different possibilities were advanced to explain this matter (Haider and Pal, 2013; Koussounadis et al., 2015; Liu et al., 2016). Considering the most highly expressed genes which did correlate well with the proteomic data in our survey, we can highlight the antibiotic resistance-related gene blaTEM and also elongation factor tufA, as well as stress response genes dps, clpB, dnaK, and groEL (Supplementary Table S3). According to the genomic and transcript sequences, various expressed genes are related to multidrug resistance mechanisms. One example is the efflux pump AcrA-AcrB-TolC located in the intermembrane structure of Gram-negative bacteria, which ejects antibiotics and other compounds from the cell, thus playing an important part in the survival of pathogenic microorganisms (Supplementary Table S2; Tikhonova and Zgurskaya, 2004; Wang et al., 2009; Du et al., 2014). Adaptor protein (AcrA) and outer membrane channel (TolC) transcripts were both detected in RNA-Seq, and the AcrA homolog AcrE, the transcriptional repressor AcrR, and the potential AcrA-repressor AcrS were all expressed but at different levels (Supplementary Table S3). AcrE is very similar to AcrA and can substitute for AcrA function in multidrug transport, while AcrR can repress acrAB operon expression (Hirakawa et al., 2008; Hayashi et al., 2016). The acrS gene is upstream of acrE, and the protein binds to the same sequence on the AcrA promoter that is recognized by AcrR, thus potentially acting as an AcrA repressor negatively regulating kanamycin resistance (Hirakawa et al., 2008). As expected, the TolC protein was identified in the membrane sub-proteome, expressed at low levels (Supplementary Table S4). Outer membrane channel TolC is involved in various efflux and drug transportation systems like the tripartite systems EmrAB–TolC and MdtABC-TolC/MdtEF-TolC, and other resistance efflux systems that confer the capability to resist and expel a wide range of antibiotics, detergents and chemical solvents (Tanabe et al., 2009; Lennen et al., 2013; Anes et al., 2015). Genes emrA, emrB, emrD, emrE, emrK, and emrR were identified in our RNA-Seq survey at low expression levels (Supplementary Table 3, below 124 FPKMs), while genes mdtA, mdtB, mdtC, mdtD, mdtE, mdtG, mdtI, mdtJ, mdtK, mdtL, mdtM, mdtN, mdtO, and mdtP showed slightly higher expression levels (above 274 FPKMs). Except for TolC, the above efflux system components were not detected in the proteome. The lipid A-Ara4N pathway is involved in polymyxin resistance because Ara4N (4-amino-4-deoxy-L-arabinose) is added to phosphate groups of lipid A. Genes encoding lipid A-Ara4N pathway components are well represented among the RNA-Seq data with arnC, arnE, arnF, and arnT expressed between 64 and 45 FPKMs (Supplementary Tables S3, S4; Gatzeva-Topalova et al., 2005b). Even though the expression levels of the latter transcripts were similar, only bifunctional polymyxin resistance protein ArnA was expressing at low level in the membrane sub-proteome. Polymyxin resistance is also triggered by the up-regulation of operon arnBCADTEF, which is directly involved in the activation of the two-component system PmrA/PmrB that is represented in the RNA-Seq readout (Olaitan et al., 2014). Genes pmrA, pmrB, pmrD, pmrG, pmrJ, pmrL, and pmrM were expressed at under 178 FPKMs whilst the respective peptides they encode were not detected. The presence of these resistance mechanisms in clinical isolates with increased virulence raises concern for the spontaneous polymyxin resistance phenomena thus indicating why such bacteria reveal high pathogenic potential. Some other abundant transcripts did not have corresponding proteins in the proteomic data, which may be due to a number of factors like post-translational mechanisms of regulation and differential protein stability that can be influenced by a protein’s location and/or interaction with other proteins, or even due to limitations within the proteomic techniques (Yoon et al., 2003; Hack, 2004; Kumar et al., 2016). In fact, the correlation between transcript and protein levels may vary according to specific patterns (Yoon et al., 2003). Immobilized pH gradient 2DE is widely used for protein separation and identification but have shown some limitations in resolving highly charged, long chain and insoluble proteins (Hack, 2004). Such proteins may therefore remain undetected with 2DE and MS techniques or displaying levels of expression below the define threshold, even when the corresponding genes and transcripts are identified through WGS and RNA-Seq, respectively. This reinforces the need to compare proteomic and transcriptomic results in order to fully characterize a given bacterial strain.
Proteins Related to Bacterial Resistance Mechanisms
Following several reports of the identification and expression of antibiotic resistance genes around the world (Lavigne et al., 2007; Mitsou et al., 2010; Barguigua et al., 2011; Kim et al., 2011), the dynamics of the proteome and the mechanism(s) of bacterial antibiotic resistance need to be considered in the context of the spread of bacterial pathogens (Cash, 2011). Elongation factor Tu, encoded by tufA, was identified in spot 46 [molecular weight (MW) 41636, isoelectric point (pI) 5.00] of the cytoplasm fraction (Figure 2). Present in most enterobacterial genomes, TufA is responsible for binding and transporting an appropriate codon-specified aminoacyl-tRNA to the ribosome aminoacyl site, and it also influences the assembly and stability of cytoskeletal polymers and is implicated in protein folding and protection from stress (Caldas et al., 1998; Isabel et al., 2008). Levels of TufA protein and transcripts were found to be elevated in C999 which is relevant and consistent with previous reports of tufA upregulated expression in the presence of antibacterial peptide polymyxin B, regulated by the pmrA/pmrB two-component system (Supplementary Table S2; Isabel et al., 2008; Ribeiro et al., 2013). Another one of the most expressed genes is β-lactamase TEM-1, which was present in the periplasmic sub-proteome [MW 31666, pI 5.60] (see Figure 6 and Supplementary Tables S3, S9). Plasmid-encoded β-lactamases are among the most critical acquired resistance determinants emerging in members of Enterobacteriaceae such as E. coli (Hooff et al., 2012). The detection of this protein is noteworthy, even though the level of expression was low and poorly correlated with the mRNA levels determined by RNA-Seq. It is also relevant to note that not any other β-lactamase protein was found expressing, unlike the corresponding gene blaCTX-M-15 frequently found carried in ST131 E. coli clones accompanied by quinolone resistance gene aac(6’)-Ib-cr (Chong et al., 2018). Similar uncorrelated levels of RNA and protein expression were found for outer membrane protein TolC [spot 351], a component of the efflux pump system which rids the cell of antibiotics like tetracycline (to which E. coli C999 is resistant) and chloramphenicol (Weatherspoon-Griffin et al., 2014). The antibiotic resistance related FabI protein, an enoyl-[acyl-carrier-protein] reductase [NADH], was detected in spot 129 [MW 28074, pI 5.58] of the whole-cell proteome and in spots 88, 89, and 146 of the cytoplasmic sub-proteome. The detection of FabI in various spots, although it occurs at low levels of protein expression, suggests the existence of post-translational modification affecting protein stability (Maier et al., 2009). FabI is a homo-tetrameric enzyme responsible for the catalysis of the last reductive step of fatty acid biosynthesis, and it is a critical target for antibacterials commonly used mediating resistance to E. coli enterohemorrhagic serotypes (see Supplementary Table S1). In Staphylococcus aureus, FabI is known to be inhibited by triclosan, a broad-spectrum antibacterial additive and hexachlorophene, which results in FabI being less effective toward Gram-negative bacteria (Heath et al., 2000; Schiebel et al., 2014). The previously cited bifunctional polymyxin resistance protein ArnA [spot 275] is a pathway-specific enzyme possessing a C-terminal domain which catalyzes the NAD+-dependent oxidative decarboxylation of UDP-GlcA to UDP-β-(L-threopentapyranosyl-4″-ulose) (UDP-4-keto-pentose) (Gatzeva-Topalova et al., 2005b). This pathway is implicated in the pathophysiological effects associated with Gram-negative bacterial infections (Gatzeva-Topalova et al., 2005a). Aminoglycoside 3′-phosphotransferase AphA [spot 73] is reported to be involved in resistance to kanamycin and structurally-related aminoglycosides like tobramycin (Shi et al., 2013). Knowing that kanamycin and tobramycin were tested when phenotyping C999, the detection of the AphA protein confirms that the corresponding resistance is expressed at the proteome level. It is interesting that while ArnA transcript levels were consistently low, the AphA transcripts were not detected, which suggests that some regulatory mechanisms remain to be discovered. In the periplasmic fraction was detected the presence of two hits of Ferrous iron transport protein A, a known virulent factor, but under a very low protein score so that its identification is not validated (Supplementary Table S9).
Stress Response, Oxidoreductase, and SOS Response
The environmental stress response is a defense mechanism found in all bacteria in which many different factors regulate gene and protein expression according to the specific stress encountered (Calabrese et al., 2012). The analysis of both the transcriptome and proteomes of C999 revealed the presence of several genes related to stress response mechanisms that increase the survival rate of bacteria, a relevant factor when considering non-commensal bacteria that will therefore endure. Stress response associated Dps (DNA protection during starvation) protein [spots 1, 6, and 157; MW 18684 and pI 5.70], another factor contributing to the bacteria’s survival, was highly expressed in both the whole-cell proteome and transcriptome (Figures 1, 2 and Supplementary Table S2). Very similar to ferritins, Dps has a compact and stable shell-like structure assembled from twelve identical subunits, with the lysine-rich N-termini of each monomer conferring flexibility. When present in stationary phase cells, Dps can bind DNA to form a highly stable DNA-Dps complex, which protects bacteria from oxidative stress or nutritional deprivation caused by harmful environmental stimuli (Stephani et al., 2003; Calhoun and Kwon, 2011). The highly stable protein conformation is also known to influence E. coli attachment to abiotic surfaces (Goulter-Thorsen et al., 2011). Expression of chaperone proteins ClpB [MW 95697, pI 5.37], DnaK (HSP70) [MW 69130, pI 4.83], and 60 kDa chaperonin GroEL1 [MW 57464, pI 4.85] is associated with the stress response. DnaK (HSP70) is an ATP-dependent molecular chaperone operating in thermal resistance in bacteria (Miot et al., 2011). In conjunction with ClpB, the DnaK/HSP70 chaperone system, is able to dissolve protein aggregates to protect bacterial cells from the effects of protein inactivation and aggregation caused by great heat stress (Doyle et al., 2007). ClpB is an ATP-dependent molecular chaperone from the AAA+ ATPase superfamily essential for bacterial thermotolerance that was found in the C999 proteomes (see Supplementary Tables S5, S6, S9; del Castillo et al., 2010; Miot et al., 2011). Another major E. coli chaperone, GroEL1, was found in whole-cell [spot 19] and also in the cytoplasm [spot 3], periplasm [spot 6] and membrane fraction [spots 18, 19, and 20] (Richter et al., 2010). GroEL belongs to the HSP60 class and plays an important role in protein folding and heat stress resistance. In fact, all three types of chaperones have similar biochemical structures and are involved in protecting cells by resisting heat stress at different stages of the bacterial chemical response (Kyratsous and Panagiotidis, 2012). In terms of oxidative stress defense, oxidoreductase function related proteins SodA [MW 23083, pI 6.44], AhpC [MW 20862, pI 5.03], and thiol peroxidase protein (Tpx) [MW 17995, pI 4.75] were identified in the C999 whole-cell proteome and AhpC was also identified in the C999 membrane fraction (see Figure 1 and Supplementary Tables S5, S8). Superoxide dismutase (SodA) removes superoxide leading to the generation of hydrogen peroxide (H2O2) which is then removed by catalases like KatE and peroxidases like AhpC, the latter being a very extensively studied bacterial peroxiredoxin system (Jung and Kim, 2003; Seib et al., 2006; Dubbs and Mongkolsuk, 2007). Tpx is involved in the formation of biofilms alongside superoxide dismutase (SodC) in Shiga toxin E. coli O157:H7 where these periplasmic oxidative defense proteins are more highly expressed under biofilm-inducing conditions (Kim et al., 2006). Peroxidases Tpx and AhpC were also found to be expressed in Salmonella enterica where a tpx mutant is more susceptible to exogenous H2O2 and is less able to degrade it than the wild type. Tpx therefore contributes to the defense system of this pathogen enabling it to survive oxidative stress (Horst et al., 2010). Another bacterial stress response mechanism involves RNA polymerase sigma factor RpoH, previously described as the main regulator of the heat stress response. RpoH is induced by protein unfolding and cytoplasmic stress in response to heat, DNA damage or antibiotic exposure (see Supplementary Table S8; Narberhaus and Balsiger, 2003; Foster, 2007). In our survey, RpoH mRNA was expressed at a high level, but protein expression was low, which might be expected as most heat induced mechanisms are post-trancriptional (Narberhaus and Balsiger, 2003). Also related to the general stress response is the two-component system connector protein sensor-associating-factor A (SafA), a 65-amino-acid membrane protein in whole cells [spots 125 and 153] and in the periplasm [spot 13] that is involved in the acid response network of two-component signal transduction systems. In E. coli there are 14 gene products and at least 15 regulators implicated in acid response (AR) biochemistry, where GadE is the main activator protein of resistance genes like gadA and gadE. Regulation of GadE in turn involves several regulators like EvgA and PhoP (Masuda and Church, 2003). EvgS/EvgA is the major system for acid resistance in exponentially-proliferating cells, inducing SafA and thus interacting and activating another connected regulating system, the PhoQ/PhoP system (Eguchi et al., 2011). Also relevant are the chaperone-related curved DNA-binding protein and the Mdh oxidoreductase identified in whole-cell [spot 76], cytoplasm [spot 73], and membrane [spot 305] fractions, and ATP-dependent protease ATP-ase subunit HslU, characteristic of E. coli O139:H28 (enterohemorrhagic strain E24377A), found in the whole-cell [spot 164] and cytoplasm [spot 24] (Marzan and Shimizu, 2011). SOS response components figured among our results. The LexA repressor [spot 147; MW 22344, pI 9.64], one of the main proteins regulating the SOS response, was expressed at a low level even though its mRNA levels were high (Figure 3 and Supplementary Tables S2, S5). LexA represses the transcription of several genes involved in DNA damage repair to a basal level when a bacterial cell is exposed to UV or to widely used antibiotics, like β-lactams, fluoroquinolones and trimethoprim (Guerin et al., 2011; Yaguchi et al., 2011). Genes lexA-regulated have been shown to exhibit phenotypic heterogeneity with different levels of expression detected in different cell subpopulations. The heterogeneous expression is related to differential binding affinity of LexA to SOS boxes when DNA is damaged by external factors invoking the SOS response (Kamensek et al., 2010). On the subject of DNA UV damage, DNA replication and repair protein RecF [spot 169; MW 40717, pI 6.78] was also found. The functional recF gene is implicated in several forms of replication such as stable DNA replication and linear plasmid multimer replication, as well as in the recovery of replication in UV-irradiated E. coli cells. The RecF protein binds preferentially to single-stranded or linear DNA that arises during DNA metabolism such as replication and normal SOS induction, and repairs DNA breaks and gaps resulting from UV or other stresses. Cells lacking RecF pathway are thus hypersensitive to UV-induced damage (Handa et al., 2009; Ona et al., 2009).
In order to find a solution to the concern multidrug-resistance in humans it is vital that researchers possess precise knowledge of the gene and protein expression of the clinical bacterial strains and whether they are related to pandemic strains such as O25:H4-ST131, allowing to understand the dynamic framework surrounding the expansion and endurance of such organisms. In our study, we followed a previous genomic profile of clinical strain E. coli C999 revealing characteristics of the extraintestinal pathogenic CTX-M-15 producing E. coli clonal group O25:H4-ST131 and exhibiting fluoroquinolone resistance as other plasmid-mediated resistances. Through transcriptomics tools we were able to confirm our strain to be O25:H4-ST131 and also identify several genes related to antibiotic resistance and survival-related processes like stress and SOS response. Proteomics allowed the identification and quantification of several proteins regarding also antibiotic resistance and stress response, within some degree of correlation to the RNA expression. While the proteomics data is very valuable, transcriptomics using RNA-Seq provide precise transcript quantification so mRNA and protein levels can be compared. However, the lack of correlation between mRNA and protein expression (or the difficulty in detecting it) indicates there is much to discover about cellular mechanisms of gene regulation that could advance our understanding of antibiotic resistance. It will be necessary to investigate such relationships, particularly in terms of specific stimuli, by increasing sampling frequency in a metaomics approach, for example. In summary, omics-based studies of the metabolic pathways of antibiotic resistance should continue to be done if answers and sustainable solutions are to be found.
LP carried out laboratory work, data analysis, and drafted the manuscript. CT, PP, CG, JN-M, and GI implemented data analyses and helped to draft the manuscript. GI, PP, and CG conceived the study and revised the manuscript. VB, JG, CS, and GI helped interpret compiled data. HS, JP, LV, and GI provided facilities and helped implementing the laboratory work. CS and LV performed WGS and RNAseq wet-lab procedures. VB and JG performed nucleic acids extraction/depletion for WGS and RNAseq, and associated bioinformatics analyses. All the authors reviewed and contributed to the manuscript, approving its submission.
LP was granted a Ph.D. fellowship by Fundação para a Ciência e a Tecnologia and European Social Fund (SFRH/BD/81307/2011). This work was supported by the Associate Laboratory for Green Chemistry – LAQV which is financed by national funds from FCT/MCTES (UID/QUI/50006/2019). Also, this work is a result of the GenomePT project (POCI-01-0145-FEDER-022184), supported by COMPETE 2020 – Operational Programme for Competitiveness and Internationalisation (POCI), Lisboa Portugal Regional Operational Programme (Lisboa2020), Algarve Portugal Regional Operational Programme (CRESC Algarve2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF), and by Fundação para a Ciência e a Tecnologia (FCT).
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2019.00831/full#supplementary-material
TABLE S1 | Antibiotic resistance genes of ESBL-producing E. coli isolate C999 identified by whole-genome sequencing and prediction using CARD software.
TABLE S2 | Summary of the metabolic pathways activated according to the total RNA sequencing of E. coli isolate C999.
TABLE S3 | Full integration of proteomic and transcriptomic data.
TABLE S4 | Integration of proteomic data of interest with corresponding transcriptomic data.
TABLE S5 | Identification of protein spots from 2DE gels of whole-cell extracts of ESBL-producing E. coli isolate C999 based on MALDI-TOF/MS sequencing results.
TABLE S6 | Identification of protein spots from 2DE gels of cytoplasmic extracts of ESBL-producing E. coli isolate C999 based on MALDI-TOF/MS sequencing results.
TABLE S7 | Identification of protein spots from 2DE gels of extracellular extracts of ESBL-producing E. coli isolate C999 based on MALDI-TOF/MS sequencing results.
TABLE S8 | Identification of protein spots from 2DE gels of membrane extracts of ESBL-producing E. coli isolate C999 based on MALDI-TOF/MS sequencing results.
TABLE S9 | Identification of protein spots from 2DE gels of periplasm extracts of ESBL-producing E. coli isolate C999 based on MALDI-TOF/MS sequencing results.
2DE, two-dimensional gel electrophoresis; ACN, acetonitrile; DTT, dithiothreitol; ESBL, extended-spectrum β-lactamase producing; FPKM, fragments per kilo base per million mapped reads; IPG, ImmobilineTM pH Gradient; MALDI-TOF/MS, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; PAGE, polyacrylamide gel; RNA-Seq, RNA sequencing; SDS, sodium dodecyl sulfate; TCA, trichloroacetic acid; WGS, whole genome sequencing.
Barguigua, A., El Otmani, F., Talmi, M., Bourjilat, F., Haouzane, F., Zerouali, K., et al. (2011). Characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from the community in Morocco. J. Med. Microbiol. 60(Pt 9), 1344–1352. doi: 10.1099/jmm.0.032482-0
Bassetti, M., Peghin, M., Trecarichi, E. M., Carnelutti, A., Righi, E., Del Giacomo, P., et al. (2017). Characteristics of Staphylococcus aureus bacteraemia and predictors of early and late mortality. PLoS One 12:e0170236. doi: 10.1371/journal.pone.0170236
Calabrese, V., Cornelius, C., Dinkova-Kostova, A. T., Iavicoli, I., Di Paola, R., Koverech, A., et al. (2012). Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochim. Biophys. Acta 1822, 753–783. doi: 10.1016/j.bbadis.2011.11.002
Calhoun, L. N., and Kwon, Y. M. (2011). Structure, function and regulation of the DNA-binding protein Dps and its role in acid and oxidative stress resistance in Escherichia coli: a review. J. Appl. Microbiol. 110, 375–386. doi: 10.1111/j.1365-2672.2010.04890.x
Chong, Y., Shimoda, S., and Shimono, N. (2018). Current epidemiology, genetic evolution and clinical impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect. Genet. Evol. 61, 185–188. doi: 10.1016/j.meegid.2018.04.005
Clermont, O., Bonacorsi, S., and Bingen, E. (2000). Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66, 4555–4558. doi: 10.1128/aem.66.10.4555-4558.2000
D’Antonio, M., D’Onorio, De Meo, P., Pallocca, M., Picardi, E., D’Erchia, A. M., et al. (2015). RAP: RNA-Seq analysis pipeline, a new cloud-based NGS web application. BMC Genomics 16:S3. doi: 10.1186/1471-2164-16-S6-S3
del Castillo, U., Fernandez-Higuero, J. A., Perez-Acebron, S., Moro, F., and Muga, A. (2010). Nucleotide utilization requirements that render ClpB active as a chaperone. FEBS Lett. 584, 929–934. doi: 10.1016/j.febslet.2010.01.029
Doyle, S. M., Hoskins, J. R., and Wickner, S. (2007). Collaboration between the ClpB AAA+ remodeling protein and the DnaK chaperone system. Proc. Natl. Acad. Sci. U.S.A. 104, 11138–11144. doi: 10.1073/pnas.0703980104
Eguchi, Y., Ishii, E., Hata, K., and Utsumi, R. (2011). Regulation of acid resistance by connectors of two-component signal transduction systems in Escherichia coli. J. Bacteriol. 193, 1222–1228. doi: 10.1128/JB.01124-10
Ewers, C., Grobbel, M., Stamm, I., Kopp, P. A., Diehl, I., Semmler, T., et al. (2010). Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals. J. Antimicrob. Chemother. 65, 651–660. doi: 10.1093/jac/dkq004
Gatzeva-Topalova, P. Z., May, A. P., and Sousa, M. C. (2005a). Crystal structure and mechanism of the Escherichia coli ArnA (PmrI) transformylase domain, an enzyme for lipid A modification with 4-amino-4-deoxy-L-arabinose and polymyxin resistance. Biochemistry 44, 5328–5338. doi: 10.1021/bi047384g
Gatzeva-Topalova, P. Z., May, A. P., and Sousa, M. C. (2005b). Structure and mechanism of ArnA: conformational change implies ordered dehydrogenase mechanism in key enzyme for polymyxin resistance. Structure 13, 929–942. doi: 10.1016/j.str.2005.03.018
Goncalves, A., Poeta, P., Monteiro, R., Marinho, C., Silva, N., Guerra, A., et al. (2014). Comparative proteomics of an extended spectrum beta-lactamase producing Escherichia coli strain from the Iberian wolf. J. Proteom. 104, 80–93. doi: 10.1016/j.jprot.2014.02.033
Goulter-Thorsen, R. M., Gentle, I. R., Gobius, K. S., and Dykes, G. A. (2011). The DNA protection during starvation protein (Dps) influences attachment of Escherichia coli to abiotic surfaces. Foodborne Pathog. Dis. 8, 939–941. doi: 10.1089/fpd.2011.0837
Guerin, E., Jove, T., Tabesse, A., Mazel, D., and Ploy, M. C. (2011). High-level gene cassette transcription prevents integrase expression in class 1 integrons. J. Bacteriol. 193, 5675–5682. doi: 10.1128/JB.05246-11
Guiral, E., Mendez-Arancibia, E., Soto, S. M., Salvador, P., Fabrega, A., Gascon, J., et al. (2011). CTX-M-15-producing enteroaggregative Escherichia coli as cause of travelers’ diarrhea. Emerg. Infect. Dis. 17, 1950–1953. doi: 10.3201/eid1710.110022
Handa, N., Morimatsu, K., Lovett, S. T., and Kowalczykowski, S. C. (2009). Reconstitution of initial steps of dsDNA break repair by the RecF pathway of E. coli. Genes Dev. 23, 1234–1245. doi: 10.1101/gad.1780709
Hayashi, K., Nakashima, R., Sakurai, K., Kitagawa, K., Yamasaki, S., Nishino, K., et al. (2016). AcrB-AcrA fusion proteins that act as multidrug efflux transporters. J. Bacteriol. 198, 332–342. doi: 10.1128/JB.00587-15
Heath, R. J., Li, J., Roland, G. E., and Rock, C. O. (2000). Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene. J. Biol. Chem. 275, 4654–4659. doi: 10.1074/jbc.275.7.4654
Hirakawa, H., Takumi-Kobayashi, A., Theisen, U., Hirata, T., Nishino, K., and Yamaguchi, A. (2008). AcrS/EnvR represses expression of the acrAB multidrug efflux genes in Escherichia coli. J. Bacteriol. 190, 6276–6279. doi: 10.1128/JB.00190-08
Hooff, G. P., van Kampen, J. J., Meesters, R. J., van Belkum, A., Goessens, W. H., and Luider, T. M. (2012). Characterization of beta-lactamase enzyme activity in bacterial lysates using MALDI-mass spectrometry. J. Proteome Res. 11, 79–84. doi: 10.1021/pr200858r
Horst, S. A., Jaeger, T., Denkel, L. A., Rouf, S. F., Rhen, M., and Bange, F. C. (2010). Thiol peroxidase protects Salmonella enterica from hydrogen peroxide stress in vitro and facilitates intracellular growth. J. Bacteriol. 192, 2929–2932. doi: 10.1128/JB.01652-09
Igrejas, G. (2000). Genetic, Biochemical and Technological Factors Associated to the Utilization Of Common Wheat (Triticum aestivum L.). PhD thesis, Univesity of Trás-os-Montes, Alto Douro. doi: 10.1128/jb.01652-09
Isabel, S., Leblanc, E., Boissinot, M., Boudreau, D. K., Grondin, M., Picard, F. J., et al. (2008). Divergence among genes encoding the elongation factor Tu of Yersinia Species. J. Bacteriol. 190, 7548–7558. doi: 10.1128/JB.01067-08
Jia, B., Raphenya, A. R., Alcock, B., Waglechner, N., Guo, P., Tsang, K. K., et al. (2017). CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res. 45, D566–D573. doi: 10.1093/nar/gkw1004</PMID<
Joensen, K. G., Tetzschner, A. M., Iguchi, A., Aarestrup, F. M., and Scheutz, F. (2015). Rapid and easy in silico serotyping of Escherichia coli isolates by use of whole-genome sequencing data. J. Clin. Microbiol. 53, 2410–2426. doi: 10.1128/JCM.00008-15
Johnson, J. R., Porter, S., Thuras, P., and Castanheira, M. (2017). The pandemic H30 subclone of sequence type 131 (ST131) as the leading cause of multidrug-resistant Escherichia coli infections in the United States (2011-2012). Open Forum Infect. Dis. 4:ofx089. doi: 10.1093/ofid/ofx089
Jung, I. L., and Kim, I. G. (2003). Transcription of ahpC, katG, and katE genes in Escherichia coli is regulated by polyamines: polyamine-deficient mutant sensitive to H2O2-induced oxidative damage. Biochem. Biophys. Res. Commun. 301, 915–922. doi: 10.1016/s0006-291x(03)00064-0
Kamensek, S., Podlesek, Z., Gillor, O., and Zgur-Bertok, D. (2010). Genes regulated by the Escherichia coli SOS repressor LexA exhibit heterogeneous expression. BMC Microbiol. 10:283. doi: 10.1186/1471-2180-10-283
Karanika, S., Karantanos, T., Arvanitis, M., Grigoras, C., and Mylonakis, E. (2016). Fecal colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis. Clin. Infect. Dis. 63, 310–318. doi: 10.1093/cid/ciw283
Kim, J., Hong, S. G., Bae, I. K., Kang, J. R., Jeong, S. H., Lee, W., et al. (2011). Emergence of Escherichia coli sequence type ST131 carrying both the blaGES-5 and blaCTX-M-15 genes. Antimicrob. Agents Chemother. 55, 2974–2975. doi: 10.1128/AAC.01703-10
Kim, Y. H., Lee, Y., Kim, S., Yeom, J., Yeom, S., Seok Kim, B., et al. (2006). The role of periplasmic antioxidant enzymes (superoxide dismutase and thiol peroxidase) of the Shiga toxin-producing Escherichia coli O157:H7 in the formation of biofilms. Proteomics 6, 6181–6193. doi: 10.1002/pmic.200600320
Koussounadis, A., Langdon, S. P., Um, I. H., Harrison, D. J., and Smith, V. A. (2015). Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system. Sci. Rep. 5:10775. doi: 10.1038/srep10775
Kumar, D., Bansal, G., Narang, A., Basak, T., Abbas, T., and Dash, D. (2016). Integrating transcriptome and proteome profiling: strategies and applications. Proteomics 16, 2533–2544. doi: 10.1002/pmic.201600140
Kyratsous, C. A., and Panagiotidis, C. A. (2012). Heat-shock protein fusion vectors for improved expression of soluble recombinant proteins in Escherichia coli. Methods Mol. Biol. 824, 109–129. doi: 10.1007/978-1-61779-433-9_5
Lavigne, J. P., Marchandin, H., Delmas, J., Moreau, J., Bouziges, N., Lecaillon, E., et al. (2007). CTX-M beta-lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors. J. Clin. Microbiol. 45, 620–626. doi: 10.1128/JCM.01917-06
Lennen, R. M., Politz, M. G., Kruziki, M. A., and Pfleger, B. F. (2013). Identification of transport proteins involved in free fatty acid efflux in Escherichia coli. J. Bacteriol. 195, 135–144. doi: 10.1128/JB.01477-12
Marzan, L. W., and Shimizu, K. (2011). Metabolic regulation of Escherichia coli and its phoB and phoR genes knockout mutants under phosphate and nitrogen limitations as well as at acidic condition. Microb. Cell Fact. 10:39. doi: 10.1186/1475-2859-10-39
Miot, M., Reidy, M., Doyle, S. M., Hoskins, J. R., Johnston, D. M., Genest, O., et al. (2011). Species-specific collaboration of heat shock proteins (Hsp) 70 and 100 in thermotolerance and protein disaggregation. Proc. Natl. Acad. Sci. U.S.A. 108, 6915–6920. doi: 10.1073/pnas.1102828108
Mitsou, E. K., Kirtzalidou, E., Pramateftaki, P., and Kyriacou, A. (2010). Antibiotic resistance in faecal microbiota of Greek healthy infants. Beneficial Microbes 1, 297–306. doi: 10.3920/BM2010.0007
Narberhaus, F., and Balsiger, S. (2003). Structure-function studies of Escherichia coli RpoH (sigma32) by in vitro linker insertion mutagenesis. J. Bacteriol. 185, 2731–2738. doi: 10.1128/jb.185.9.2731-2738.2003
Nicolas-Chanoine, M. H., Blanco, J., Leflon-Guibout, V., Demarty, R., Alonso, M. P., Canica, M. M., et al. (2008). Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61, 273–281. doi: 10.1093/jac/dkm464
Ona, K. R., Courcelle, C. T., and Courcelle, J. (2009). Nucleotide excision repair is a predominant mechanism for processing nitrofurazone-induced DNA damage in Escherichia coli. J. Bacteriol. 191, 4959–4965. doi: 10.1128/JB.00495-09
Peirano, G., and Pitout, J. D. (2010). Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 35, 316–321. doi: 10.1016/j.ijantimicag.2009.11.003
Ribeiro, C. B., Sobral, M. G., Tanaka, C. L., Dallagassa, C. B., Picheth, G., Rego, F. G., et al. (2013). Proteins differentially expressed by Shiga toxin-producing Escherichia coli strain M03 due to the biliar salt sodium deoxycholate. Genet. Mol. Res. 12, 4909–4917. doi: 10.4238/2013.October.24.1
Ruiz, E., Saenz, Y., Zarazaga, M., Rocha-Gracia, R., Martinez-Martinez, L., Arlet, G., et al. (2012). qnr, aac(6’)-Ib-cr and qepA genes in Escherichia coli and Klebsiella spp.: genetic environments and plasmid and chromosomal location. J. Antimicrob. Chemother. 67, 886–897. doi: 10.1093/jac/dkr548
Ruiz, J., Simon, K., Horcajada, J. P., Velasco, M., Barranco, M., Roig, G., et al. (2002). Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J. Clin. Microbiol. 40, 4445–4449. doi: 10.1128/jcm.40.12.4445-4449.2002
Salipante, S. J., SenGupta, D. J., Cummings, L. A., Land, T. A., Hoogestraat, D. R., and Cookson, B. T. (2015). Application of whole-genome sequencing for bacterial strain typing in molecular epidemiology. J. Clin. Microbiol. 53, 1072–1079. doi: 10.1128/JCM.03385-14
Schiebel, J., Chang, A., Shah, S., Lu, Y., Liu, L., Pan, P., et al. (2014). Rational design of broad spectrum antibacterial activity based on a clinically relevant enoyl-acyl carrier protein (ACP) reductase inhibitor. J. Biol. Chem. 289, 15987–16005. doi: 10.1074/jbc.M113.532804
Seib, K. L., Wu, H. J., Kidd, S. P., Apicella, M. A., Jennings, M. P., and McEwan, A. G. (2006). Defenses against oxidative stress in Neisseria gonorrhoeae: a system tailored for a challenging environment. Microbiol. Mol. Biol. Rev. 70, 344–361. doi: 10.1128/MMBR.00044-05
Shi, K., Caldwell, S. J., Fong, D. H., and Berghuis, A. M. (2013). Prospects for circumventing aminoglycoside kinase mediated antibiotic resistance. Front. Cell. Infect. Microbiol. 3:22. doi: 10.3389/fcimb.2013.00022
Stephani, K., Weichart, D., and Hengge, R. (2003). Dynamic control of Dps protein levels by ClpXP and ClpAP proteases in Escherichia coli. Mol. Microbiol. 49, 1605–1614. doi: 10.1046/j.1365-2958.2003.03644.x
Taddei, C. R., Oliveira, F. F., Piazza, R. M., Paes Leme, A. F., Klitzke, C. F., Serrano, S. M., et al. (2011). A comparative study of the outer membrane proteome from an atypical and a typical enteropathogenic Escherichia coli. Open Microbiol. J. 5, 83–90. doi: 10.2174/1874285801105010083
Tanabe, M., Szakonyi, G., Brown, K. A., Henderson, P. J., Nield, J., and Byrne, B. (2009). The multidrug resistance efflux complex, EmrAB from Escherichia coli forms a dimer in vitro. Biochem. Biophys. Res. Commun. 380, 338–342. doi: 10.1016/j.bbrc.2009.01.081
Tikhonova, E. B., and Zgurskaya, H. I. (2004). AcrA, AcrB, and TolC of Escherichia coli form a stable intermembrane multidrug efflux complex. J. Biol. Chem. 279, 32116–32124. doi: 10.1074/jbc.M402230200
Vimont, S., Boyd, A., Bleibtreu, A., Bens, M., Goujon, J. M., Garry, L., et al. (2012). The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities. PLoS One 7:e46547. doi: 10.1371/journal.pone.0046547
Vlaanderen, J., Moore, L. E., Smith, M. T., Lan, Q., Zhang, L., Skibola, C. F., et al. (2010). Application of OMICS technologies in occupational and environmental health research; current status and projections. Occupat. Environ. Med. 67, 136–143. doi: 10.1136/oem.2008.042788
Weatherspoon-Griffin, N., Yang, D., Kong, W., Hua, Z., and Shi, Y. (2014). The CpxR/CpxA two-component regulatory system up-regulates the multidrug resistance cascade to facilitate Escherichia coli resistance to a model antimicrobial peptide. J. Biol. Chem. 289, 32571–32582. doi: 10.1074/jbc.M114.565762
Xia, X. X., Han, M. J., Lee, S. Y., and Yoo, J. S. (2008). Comparison of the extracellular proteomes of Escherichia coli B and K-12 strains during high cell density cultivation. Proteomics 8, 2089–2103. doi: 10.1002/pmic.200700826
Yaguchi, K., Mikami, T., Igari, K., Yoshida, Y., Yokoyama, K., and Makino, K. (2011). Identification of LexA regulated promoters in Escherichia coli O157:H7. J. Gen. Appl. Microbiol. 57, 219–230. doi: 10.2323/jgam.57.219
Keywords: bacteria, antimicrobial resistance, public health, genomics, transcriptomics, proteomics
Citation: Pinto L, Torres C, Gil C, Nunes-Miranda JD, Santos HM, Borges V, Gomes JP, Silva C, Vieira L, Pereira JE, Poeta P and Igrejas G (2019) Multiomics Assessment of Gene Expression in a Clinical Strain of CTX-M-15-Producing ST131 Escherichia coli. Front. Microbiol. 10:831. doi: 10.3389/fmicb.2019.00831
Received: 30 November 2018; Accepted: 01 April 2019;
Published: 03 May 2019.
Edited by:Dongsheng Zhou, Beijing Institute of Microbiology and Epidemiology, China
Reviewed by:Asad U. Khan, Aligarh Muslim University, India
Yvonne Pfeifer, Robert Koch Institute, Germany
Copyright © 2019 Pinto, Torres, Gil, Nunes-Miranda, Santos, Borges, Gomes, Silva, Vieira, Pereira, Poeta and Igrejas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Gilberto Igrejas, firstname.lastname@example.org